Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

Author: Sebban Catherine  

Publisher: Springer Publishing Company

ISSN: 0941-4355

Source: Supportive Care in Cancer, Vol.16, Iss.9, 2008-09, pp. : 1017-1023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract